Cathay Biotech, Inc.

  • Market Cap: Large Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE100004447
CNY
45.43
-0.51 (-1.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,922.12
2,086.47
2,416.19
2,340.54
1,482.42
1,898.55
1,740.66
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,922.12
2,086.47
2,416.19
2,340.54
1,482.42
1,898.55
1,740.66
Raw Material Cost
2,099.52
1,555.50
1,650.70
1,558.42
781.60
1,090.41
1,016.84
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
33.47
37.87
24.62
16.89
4.17
17.58
3.87
Selling and Distribution Expenses
183.85
178.97
181.25
152.52
174.67
185.70
168.65
Other Expenses
17.60
13.81
15.25
10.92
7.06
6.42
7.50
Total Expenditure (Excl Depreciation)
2,492.84
1,910.44
2,009.03
1,837.02
1,031.01
1,357.87
1,264.34
Operating Profit (PBDIT) excl Other Income
429.3
176
407.2
503.5
451.4
540.7
476.3
Other Income
239.99
343.93
343.72
243.33
76.35
25.44
70.27
Operating Profit (PBDIT)
915.90
784.21
994.12
916.52
640.01
682.46
619.18
Interest
33.47
37.87
24.62
16.89
4.17
17.58
3.87
Exceptional Items
0.00
0.00
0.00
0.00
9.15
8.05
0.00
Gross Profit (PBDT)
822.60
530.97
765.49
782.12
700.81
808.15
723.82
Depreciation
325.46
289.60
269.80
172.22
120.59
117.66
73.08
Profit Before Tax
556.97
456.74
699.70
727.41
524.40
555.27
542.23
Tax
73.43
40.39
83.34
90.94
63.45
76.99
74.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
488.96
366.52
553.27
594.72
457.67
478.88
466.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
488.96
366.52
553.27
594.72
457.67
478.88
466.29
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-14.37
42.01
59.39
38.79
-0.33
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
474.59
408.54
612.65
633.51
457.34
478.88
466.29
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
11,507.01
11,164.18
10,948.96
10,651.92
10,384.74
4,641.86
3,156.74
Earnings per share (EPS)
0.84
0.63
0.95
1.43
1.1
1.15
1.12
Diluted Earnings per share
0.84
0.63
0.95
1.43
1.1
1.15
1.12
Operating Profit Margin (Excl OI)
11.99%
7.22%
15.75%
21.4%
29.89%
28.41%
27.34%
Gross Profit Margin
30.2%
35.77%
40.13%
38.44%
43.51%
35.44%
35.35%
PAT Margin
16.73%
17.57%
22.9%
25.41%
30.87%
25.22%
26.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 40.05% vs -13.65% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 16.18% vs -33.33% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 53.51% vs -32.30% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -11.61% vs 54.07% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Cathay Biotech, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,922.12
0
2,922.12
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,922.12
0
2,922.12
Raw Material Cost
2,099.52
0
2,099.52
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
33.47
0
33.47
Selling and Distribution Expenses
183.85
0
183.85
Other Expenses
17.60
0.00
17.60
Total Expenditure (Excl Depreciation)
2,492.84
0
2,492.84
Operating Profit (PBDIT) excl Other Income
429.29
0.00
429.29
Other Income
239.99
0
239.99
Operating Profit (PBDIT)
915.90
0
915.90
Interest
33.47
0
33.47
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
822.60
0
822.60
Depreciation
325.46
0
325.46
Profit Before Tax
556.97
0
556.97
Tax
73.43
0
73.43
Provisions and contingencies
0
0
0.00
Profit After Tax
488.96
0
488.96
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
488.96
0
488.96
Share in Profit of Associates
0
0
0.00
Minority Interest
-14.37
0
-14.37
Other related items
0.00
0.00
0.00
Consolidated Net Profit
474.59
0
474.59
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
11,507.01
0
11,507.01
Earnings per share (EPS)
0.84
0
0.84
Diluted Earnings per share
0.84
0
0.84
Operating Profit Margin (Excl OI)
11.99%
0%
0.00
11.99%
Gross Profit Margin
30.20%
0%
0.00
30.20%
PAT Margin
16.73%
0%
0.00
16.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 292.21 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 40.05% vs -13.65% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 47.46 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 16.18% vs -33.33% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 67.59 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 53.51% vs -32.30% in Dec 2023

Annual - Interest
Interest 3.35 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -11.61% vs 54.07% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.99%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023